Turner's syndrome is a chromosomal disorder involving many physical abnormalities; these include short stature and slow growth rate. Short stature has been treated with anabolic steroids, low doses of estrogen, and/or hGH (1) (2) (3) (4) (5) . Human GH treatment has not been systema¬ tically employed because of the lack of hGH supply. Since the successful synthesis of hGH by recombinant DNA technology (6) , several investigators have reported the safety and biological activities of recombinant hGH (rhGH) in humans (7) (8) (9) (10) . Recently, larger numbers of Turner patients have commenced treatment with r-hGH (11) (12) (13) (14) (15) Age (Years) Fig. 3 
